Misplaced Pages

This is an old revision of this page, as edited by Leodmacleod (talk | contribs) at 01:07, 26 March 2010 (→Routes of administration: Re-added picture with more encyclopedic caption. Please feel free to remove if that seems like too much developement). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Cannabis
Dried flowers from the Cannabis sativa plant. Note the visible trichomes (commonly known as "crystals"), which contain large quantities of THC, CBD and other cannabinoids.
Scientific classification
Kingdom:	Plantae
Phylum:	Magnoliophyta
Class:	Magnoliopsida
Order:	Rosales
Family:	Cannabaceae
Genus:	Cannabis
Species:	C. sativa
Binomial name
Cannabis sativa L. Cannabis indica Lam. (putative)

Cannabis, also known as marijuana, marihuana, and ganja (from Template:Lang-sa gañjā, meaning "hemp"), among many other names, refers to any number of preparations of the Cannabis plant intended for use as a psychoactive drug. The most common form of cannabis used as a drug is the dried herbal form.

The typical herbal form of cannabis consists of the flowers and subtending leaves and stalks of mature pistillate or female plants. The resinous form of the drug is known as hashish (or merely as 'hash').

The major psychoactive chemical compound in cannabis is Δ-tetrahydrocannabinol (commonly abbreviated as THC). At least 66 other cannabinoids are also present in cannabis, including cannabidiol (CBD), cannabinol (CBN) and tetrahydrocannabivarin (THCV) among many others, which are believed to result in different effects than those of THC alone.

Cannabis use has been found to have occurred as long ago as the third millennium B.C. In modern times, the drug has been used for recreational, religious or spiritual, and medicinal purposes. The United Nations (UN) estimated that in 2004 about 4% of the world's adult population (162 million people) use cannabis annually, and about 0.6% (22.5 million) use it on a daily basis. The possession, use, or sale of cannabis preparations containing psychoactive cannabinoids became illegal in most parts of the world in the early twentieth century. Since then, some countries have intensified the enforcement of cannabis prohibition, while others have reduced it.

History

Cannabis is indigenous to Central and South Asia. Evidence of the inhalation of cannabis smoke can be found as far back as the 3rd millennium B.C., as indicated by charred cannabis seeds found in a ritual brazier at an ancient burial site in present day Romania. Cannabis is also known to have been used by the ancient Hindus and Nihang Sikhs of India and Nepal thousands of years ago. The herb was called ganjika in Sanskrit (गांजा/গাঁজা ganja in modern Indic languages). The ancient drug soma, mentioned in the Vedas as a sacred intoxicating hallucinogen, was sometimes associated with cannabis.

Cannabis was also known to the ancient Assyrians, who discovered its psychoactive properties through the Aryans. Using it in some religious ceremonies, they called it qunubu (meaning "way to produce smoke"), a probable origin of the modern word "cannabis". Cannabis was also introduced by the Aryans to the Scythians and Thracians/Dacians, whose shamans (the kapnobatai—"those who walk on smoke/clouds") burned cannabis flowers to induce a state of trance. Members of the cult of Dionysus, believed to have originated in Thrace (Bulgaria, Greece and Turkey), are also thought to have inhaled cannabis smoke. In 2003, a leather basket filled with cannabis leaf fragments and seeds was found next to a 2,500- to 2,800-year-old mummified shaman in the northwestern Xinjiang Uygur Autonomous Region of China.

Cannabis has an ancient history of ritual use and is found in pharmacological cults around the world. Hemp seeds discovered by archaeologists at Pazyryk suggest early ceremonial practices like eating by the Scythians occurred during the 5th to 2nd century B.C., confirming previous historical reports by Herodotus. One writer has claimed that cannabis was used as a religious sacrament by ancient Jews and early Christians due to the similarity between the Hebrew word "qannabbos" ("cannabis") and the Hebrew phrase "qené bósem" ("aromatic cane"). It was used by Muslims in various Sufi orders as early as the Mamluk period, for example by the Qalandars.

A study published in the South African Journal of Science showed that "pipes dug up from the garden of Shakespeare's home in Stratford upon Avon contain traces of cannabis." The chemical analysis was carried out after researchers hypothesized that the "noted weed" mentioned in Sonnet 76 and the "journey in my head" from Sonnet 27 could be references to cannabis and the use thereof.

Cannabis was criminalized in the United States in 1937 due to Marihuana Tax Act of 1937. Several theories try to explain why it is illegal in most Western societies. Jack Herer, a cannabis legalization activist and writer, argues that the economic interests of the paper and chemical industry were a driving force to make it illegal. Another explanation is that beneficial effects of hemp would lower the profit of pharmaceutical companies which therefore have a vital interest to keep cannabis illegal. Those economic theories were criticized for not taking social aspect into account. The illegalization was rather a result of racism directed to associate American immigrants of Mexican and African descent with cannabis abuse.

Forms

Cannabis (herbal form)

The terms cannabis or marijuana generally refer to the dried flowers and subtending leaves and stems of the female cannabis plant. This is the most widely consumed form, containing 3% to 22% THC. In contrast, cannabis strains used to produce industrial hemp contain less than 1% THC and are thus not valued for recreational use.

Hashish

Hashish (also spelled hasheesh), hashisha, or simply hash is a concentrated resin produced from the flowers of the female cannabis plant. Hash can often be more potent than marijuana and can be smoked or chewed. It varies in color from black to golden brown depending upon purity.

According to both the "Talk to FRANK" website and the UKCIA website, "Soap Bar", "perhaps the most common type of hash found in the UK", can contain turpentine, tranquillizers, boot polish, henna and animal faeces - amongst several other things. One small study of five soap-bar samples seized by UK Customs in 2001 found huge adulteration by many toxic substances, including soil, glue, engine oil and animal faeces.

Hash oil

Hash oil, or honey oil, is an essential oil extracted from the cannabis plant through the use of various solvents. It has a high proportion of cannabinoids (ranging from 40–90%). This oil is also used in the process of making a variety of cannabis foods.

Kief

Kief is a powder made from trichomes removed from the leaves and flowers of cannabis plants. Kief can be compressed to produce cakes of hashish, or consumed in powder form.

Residue

Because of THC's adhesive properties, a sticky residue builds up inside the paraphernalia when cannabis is smoked. It has tar-like properties but still contains THC as well as other cannabinoids. This buildup still has all the psychoactive properties of cannabis but is more difficult to smoke due to the discomfort caused to the throat and lungs. Cannabis users typically only smoke residue when cannabis is unavailable. Glass may be water-steamed at a low temperature prior to scraping in order to make the residue easier to remove.

Potency

According to the United Nations Office on Drugs and Crime (UNODC), "the amount of THC present in a cannabis sample is generally used as a measure of cannabis potency." The three main forms of cannabis products are the herb (marijuana), resin (hashish), and oil (hash oil). The UNODC states that marijuana often contains 5% THC content, resin "can contain up to 20% THC content", and that "Cannabis oil may contain more than 60% THC content.".

A scientific study published in 2000 in the Journal of Forensic Sciences (JFS) found that the potency (THC content) of confiscated cannabis in the United States (US) rose from "approximately 3.3% in 1983 and 1984", to "4.47% in 1997". It also concluded that "other major cannabinoids (i.e., CBD, CBN, and CBC)" (other chemicals in cannabis) "showed no significant change in their concentration over the years". More recent research undertaken at the University of Mississippi's Potency Monitoring Project has found that average THC levels in cannabis samples between 1975 and 2007 have increased from 4% in 1983 to 9.6% in 2007.

Australia's National Cannabis Prevention and Information Centre (NCPIC) states that the buds (flowers) of the female cannabis plant contain the highest concentration of THC, followed by the leaves. The stalks and seeds have "much lower THC levels". The UN states that the leaves can contain ten times less THC than the buds, and the stalks one hundred times less THC.

According to the "Talk to FRANK" (UK) website:

"Recently, there has been an increased availability of strong herbal cannabis, containing on average 2-3 times the amount of the active compound, tetrahydrocannabinol or THC, as compared to the traditional imported ‘weed’. This strong cannabis includes:‘sinsemilla’ (a bud grown in the absence of male plants and which has no seeds); ‘homegrown’; ‘skunk’, which has a characteristic strong smell; and imported ‘netherweed’...

...it may not be possible to tell whether a particular sample of 'skunk' or ‘homegrown’ or ‘sinsemilla’ will have a higher potency than an equal amount of traditional herbal cannabis

Of course, "homegrown", "netherweed" and "sinsemilla" are not always "strong". The selection of "skunk" strains generally are, although not every strain of cannabis with a "characteristic strong smell" can be accurately named "skunk". "Traditional herbal cannabis" or "weed", has on the whole, always been subjectively "strong" and thus FRANK leaves his website uncited.

Routes of administration

Cannabis is consumed in many different ways, most of which involve inhaling smoke.

The most commonly used include wire-screened bowls, bubblers (small pipes with water chambers), bongs, one-hitters, chillums, paper-wrapped joints and tobacco-leaf-wrapped blunts.

A vaporizer heats herbal cannabis to 365–410°F (185–210°C), which causes the active ingredients to evaporate into a gas without burning the plant material (the boiling point of THC is 390.4°F (200°C) at 760 mmHg pressure). A lower proportion of toxic chemicals are released than by smoking, although this may vary depending on the design of the vaporizer and the temperature at which it is set. This method of consuming cannabis produces markedly different effects than smoking due to the flash points of different cannabinoids; for example, CBN has a flash point of 212.7°C and would normally be present in smoke but might not be present in vapor.

As an alternative to smoking, cannabis may be consumed orally. However, the cannabis or its extract must be sufficiently heated or dehydrated to cause decarboxylation of its most abundant cannabinoid, tetrahydrocannabinolic acid (THCA), into psychoactive THC.

Cannabinoids can be leached from cannabis plant matter using high-proof spirits (often grain alcohol) to create a tincture, often referred to as Green Dragon.

Cannabis can also be consumed as a tea. THC is lipophilic and only slightly water soluble (with a solubility of 2.8 mg per liter), so tea is made by first adding a saturated fat to hot water (i.e. cream or any milk except skim) with a small amount of cannabis, green or black tea leaves and honey or sugar, steeped for approximately 5 minutes.

Effects

Cannabis has psychoactive and physiological effects when consumed. The minimum amount of THC required to have a perceptible psychoactive effect is about 10 micrograms per kilogram of body weight. Aside from a subjective change in perception and, most notably, mood, the most common short-term physical and neurological effects include increased heart rate, lowered blood pressure, impairment of short-term episodic memory, working memory, psychomotor coordination, and concentration. Long-term effects are less clear.

Classification

While many drugs clearly fall into the category of either stimulant, depressant, or hallucinogen, cannabis exhibits a mix of all properties, perhaps leaning the most towards hallucinogen or psychedelic properties, though with other effects quite pronounced as well. Though THC is typically considered the primary active component of the cannabis plant, various scientific studies have suggested that certain other cannabinoids like CBD may also play a significant role in its psychoactive effects.

Medical use

Cannabis used medically does have several well-documented beneficial effects. Among these are: the amelioration of nausea and vomiting, stimulation of hunger in chemotherapy and AIDS patients, lowered intraocular eye pressure (shown to be effective for treating glaucoma), as well as general analgesic effects (pain reliever).

Less confirmed individual studies also have been conducted indicating cannabis to be beneficial to a gamut of conditions running from multiple sclerosis to depression. Synthesized cannabinoids are also sold as prescription drugs, including Marinol (dronabinol in the United States and Germany) and Cesamet (nabilone in Canada, Mexico, The United States and The United Kingdom).

Currently, the U.S. Food and Drug Administration (FDA) has not approved smoked marijuana for any condition or disease in the United States, largely because good quality scientific evidence for its use from U.S. studies is lacking; however, a major barrier to acquiring the necessary evidence is the lack of federal funding for this kind of research. Regardless, thirteen states have legalized cannabis for medical use. Canada, Spain, The Netherlands and Austria have also legalized cannabis for medicinal use.

Long-term effects

The smoking of cannabis is the most harmful method of consumption, as the inhalation of smoke from organic materials can cause various health problems.

By comparison, studies on the vaporization of cannabis found that subjects were "only 40% as likely to report respiratory symptoms as users who do not vaporize, even when age, sex, cigarette use, and amount of cannabis consumed are controlled." Another study found vaporizers to be "a safe and effective cannabinoid delivery system."

While a study in New Zealand of 79 lung-cancer patients suggested daily cannabis smokers have a 5.7 times higher risk of lung cancer than non-users, another study of 2252 people in Los Angeles failed to find a correlation between the smoking of cannabis and lung, head or neck cancers. These effects have been attributed to the well documented anti-tumoral properties of cannabinoids, specifically tetrahydrocannabinol (THC) and cannabidiol. Some studies have also found that moderate cannabis use may protect against head and neck cancers, as well as lung cancer. Some studies have shown that cannabidiol may also be useful in treating breast cancer.

Cannabis use has been assessed by several studies to be correlated with the development of anxiety, psychosis, and depression. Indeed, a 2007 meta-analysis estimated that cannabis use is statistically associated, in a dose-dependent manner, to an increased risk in the development of psychotic disorders, including schizophrenia. No causal mechanism has been proven, however, and the meaning of the correlation and its direction is a subject of debate that has not been resolved in the scientific community. Some studies assess that the causality is more likely to involve a path from cannabis use to psychotic symptoms rather than a path from psychotic symptoms to cannabis use, while other studies assess the opposite direction of the causality, or hold cannabis to only form parts of a "causal constellation", while not inflicting mental health problems that would not have occurred in the absence of the cannabis use.

Though cannabis use has at times been associated with stroke, there is no firmly established link, and potential mechanisms are unknown. Similarly, there is no established relationship between cannabis use and heart disease, including exacerbation of cases of existing heart disease. Though some fMRI studies have shown changes in neurological function in long term heavy cannabis users, no long term behavioral effects after abstinence have been linked to these changes.

Adulterants

Adulterants in cannabis are less common than in other drugs of abuse. Chalk (in the Netherlands) and glass particles (in the UK) have been used at times to make cannabis appear to be higher quality. Increasing the weight of hashish products in Germany with lead caused lead intoxication in at least 29 users. In the Netherlands two chemical analogs of Sildenafil (Viagra) were found in adulterated marijuana.

Gateway drug theory

Some claim that trying cannabis increases the probability that users will eventually use "harder" drugs. This hypothesis has been one of the central pillars of anti-cannabis drug policy in the United States, though the validity and implications of these hypotheses are highly debated. Studies have shown that tobacco smoking is a better predictor of concurrent illicit hard drug use than smoking cannabis.

No widely accepted study has ever demonstrated a cause-and-effect relationship between the use of cannabis and the later use of harder drugs like heroin and cocaine. However, the prevalence of tobacco cigarette advertising and the practice of mixing tobacco and cannabis together in a single large joint, common in Europe, are believed to be a factor in promoting nicotine dependency among young persons investigating cannabis.

A 2005 comprehensive review of the literature on the cannabis gateway hypothesis found that pre-existing traits may predispose users to addiction in general, the availability of multiple drugs in a given setting confounds predictive patterns in their usage, and drug sub-cultures are more influential than cannabis itself. The study called for further research on "social context, individual characteristics, and drug effects" to discover the actual relationships between cannabis and the use of other drugs.

A new user of cannabis who feels there is a difference between anti-drug information and their own experiences will apply this distrust to public information about other, more powerful drugs. Some studies state that while there is no proof for this gateway hypothesis, young cannabis users should still be considered as a risk group for intervention programs. Other findings indicate that hard drug users are likely to be "poly-drug" users, and that interventions must address the use of multiple drugs instead of a single hard drug.

Another gateway hypothesis is that while cannabis is not as harmful or addictive as other drugs, a gateway effect may be detected as a result of the "common factors" involved with using any illegal drug. Because of its illegal status, cannabis users are more likely to be in situations which allow them to become acquainted with people who use and sell other illegal drugs. By this argument, some studies have shown that alcohol and tobacco may be regarded as gateway drugs. However, a more parsimonious explanation could be that cannabis is simply more readily available (and at an earlier age) than illegal hard drugs, and alcohol/tobacco are in turn easier to obtain earlier than cannabis (though the reverse may be true in some areas), thus leading to the "gateway sequence" in those people who are most likely to experiment with any drug offered.

Legal status

Since the beginning of the 20th century, most countries have enacted laws against the cultivation, possession, or transfer of cannabis for recreational use. These laws have impacted adversely on the cannabis plant's cultivation for non-recreational purposes, but there are many regions where, under certain circumstances, handling of cannabis is legal or licensed. Many jurisdictions have lessened the penalties for possession of small quantities of cannabis, so that it is punished by confiscation and sometimes a fine, rather than imprisonment, focusing more on those who traffic the drug on the black market.

In some areas where cannabis use has been historically tolerated, some new restrictions have been put in place, such as the closing of cannabis coffee shops near the borders of the Netherlands, closing of coffee shops near secondary schools in the Netherlands and crackdowns on "Pusher Street" in Christiania, Copenhagen in 2004.

Some jurisdictions use free voluntary treatment programs and/or mandatory treatment programs for frequent known users. Simple possession can carry long prison terms in some countries, particularly in East Asia, where the sale of cannabis may lead to a sentence of life in prison or even execution.

Price

The price or street value of cannabis varies strongly by region and area. In addition, some dealers may sell potent buds at a higher price.

In the United States, cannabis is overall the #4 value crop, and is #1 or #2 in many states including California, New York and Florida, averaging $3,000/lb. It is believed to generate an estimated $36 billion market. Most of the money is spent not on growing and producing but on smuggling the supply to buyers. The United Nations Office on Drugs and Crime claims in its 2008 World Drug Report that typical U.S. retail prices are 10-15 dollars per gram (approximately $290 to $430 per ounce). Street prices in North America are known to range at about $150 to $250 per ounce.

The European Monitoring Centre for Drugs and Drug Addiction reports that typical retail prices in Europe for cannabis varies from 2€ to 14€ per gram, with a majority of European countries reporting prices in the range 4–10€. In the United Kingdom, a cannabis plant has an approximate street value of £300.

Truth serum

Cannabis was used as a truth serum by the Office of Strategic Services (OSS), a US government intelligence agency formed during World War II. In the early 1940s, it was the most effective truth drug developed at the OSS labs at St. Elizabeths Hospital; it caused a subject "to be loquacious and free in his impartation of information."

In May 1943, Major George Hunter White, head of OSS counter-intelligence operations in the US, arranged a meeting with Augusto Del Gracio, an enforcer for gangster Lucky Luciano. Del Gracio was given cigarettes spiked with THC concentrate from cannabis, and subsequently talked openly about Luciano's heroin operation. On a second occasion the dosage was increased such that Del Gracio passed out for two hours.

Breeding and cultivation

It is often claimed by growers and breeders of herbal cannabis that advances in breeding and cultivation techniques have increased the potency of cannabis since the late 1960s and early '70s, when THC was first discovered and understood. However, potent seedless marijuana such as "Thai sticks" were already available at that time. Sinsemilla (Spanish for "without seed") is the dried, seedless inflorescences of female cannabis plants. Because THC production drops off once pollination occurs, the male plants (which produce little THC themselves) are eliminated before they shed pollen to prevent pollination. Advanced cultivation techniques such as hydroponics, cloning, high-intensity artificial lighting, and the sea of green method are frequently employed as a response (in part) to prohibition enforcement efforts that make outdoor cultivation more risky. These intensive horticultural techniques have made it possible to grow strains with fewer seeds and higher potency. It is often cited that the average levels of THC in cannabis sold in United States rose dramatically between the 1970s and 2000, but such statements are likely skewed because of undue weight given to much more expensive and potent, but less prevalent samples.

"Skunk" refers to several named strains of potent cannabis, grown through selective breeding and often hydroponics. It is a cross-breed of Cannabis sativa and C. indica (although other strains of this mix exist in abundance). Skunk cannabis potency ranges usually from 6% to 15% and rarely as high as 20%. The average THC level in coffee shops in the Netherlands is about 18–19%.

Skunk can sometimes be incorrectly mistaken for all types of female herbal cannabis.

After revisions to cannabis rescheduling in the UK, the government moved cannabis back from a class C to a class B drug. A purported reason was the appearance of high potency cannabis.

It is noted that one of the earliest strains of skunk to appear was that of "SKUNK #1", which has been inbred since 1978. High potency herbal cannabis has been around potentially, even longer.

A Dutch double-blind, randomized, placebo-controlled, cross-over study examining male volunteers aged 18–45 years with a self-reported history of regular cannabis use concluded that smoking of cannabis with high THC levels (marijuana with 9–23% THC), as currently sold in coffee shops in the Netherlands, may lead to higher THC blood-serum concentrations. This is reflected by an increase of the occurrence of impaired psychomotor skills, particularly among younger or inexperienced cannabis smokers, who do not adapt their smoking style to the higher THC content. High THC concentrations in cannabis was associated with a dose-related increase of physical effects (such as increase of heart rate, and decrease of blood pressure) and psychomotor effects (such as reacting more slowly, being less concentrated, making more mistakes during performance testing, having less motor control, and experiencing drowsiness). It was also observed during the study that the effects from a single joint at times lasted for more than eight hours. Reaction times remained impaired five hours after smoking, when the THC serum concentrations were significantly reduced, but still present. The researchers suggested that THC may accumulate in blood-serum when cannabis is smoked several times per day.

Another study showed that consumption of 15 mg of Δ-THC resulted in no impairment to learning whatsoever occurring over a three-trial selective reminding task after two hours. In several tasks, Δ-THC increased both speed and error rates, reflecting “riskier” speed–accuracy trade-offs.

See also

Cannabis plant

• Bhang
• Cannabinoids
  • Cannabidiol (CBD)
  • Cannabinol (CBN)
  • Tetrahydrocannabinol (THC)
  • Tetrahydrocannabivarin (THCV)
• cannabis strains
• Hash or hashish
• Hash oil or honey oil
• Hemp oil
• Kief

Cannabis health

• Medical Cannabis

Cannabis legality

• 1937 Marihuana Tax Act
• Cannabis political parties
• Global Marijuana March
• International Opium Convention
• Legal and medical status of cannabis
• Legality of cannabis by country
• Marijuana Control, Regulation, and Education Act
• Marijuana Policy Project
• National Organization for the Reform of Marijuana Laws
• List of drugs illegal in the United Kingdom

Cannabis use demographics

• Adult lifetime cannabis use by country
• Annual cannabis use by country

Notes

Footnotes

 a: Weed, pot, buddha or bud, Mary Jane, grass, herb, dope, schwag, and reefer, are among the many other nicknames for marijuana or cannabis as a drug.
 b: Sources for this section (as well as far more information) can be found in the Medical cannabis article.

Citations

1. ^ John H. Wiersema. "Cannabis sativa information from NPGS/GRIN". Ars-grin.gov. Retrieved 2010-01-02.
2. See, Etymology of marijuana.
3. Company, Houghton Mifflin (2007-11-14). Spanish Word Histories and Mysteries. Houghton Mifflin Harcourt. p. 142. ISBN 0618910549, 9780618910540. {{cite book}}: |last= has generic name (help); Check |isbn= value: invalid character (help); Unknown parameter |coauthors= ignored (|author= suggested) (help)
4. Matthew J. Atha (Independent Drug Monitoring Unit). "Types of Cannabis Available in the United Kingdom (UK)".
5. Fusar-Poli P, Crippa JA, Bhattacharyya S; et al. (2009). "Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing". Archives of General Psychiatry. 66 (1): 95–105. doi:10.1001/archgenpsychiatry.2008.519. PMID 19124693. Retrieved 2009-09-26. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
6. ^ Rudgley, Richard (1998). Lost Civilisations of the Stone Age. New York: Free Press. ISBN 0-6848-5580-1.
7. United Nations Office on Drugs and Crime (2006). Cannabis: Why We Should Care (PDF). Vol. 1. S.l.: United Nations. p. 14. ISBN 9-2114-8214-3. {{cite book}}: |journal= ignored (help)
8. ^ Stafford, Peter (1992). Psychedelics Encyclopedia. Berkeley, California: Ronin Publishing, Inc. ISBN 0-914171-51-8. Cite error: The named reference "bookPsychedelics Encyclopedia" was defined multiple times with different content (see the help page).
9. Matthews, A.; Matthews, L. (2007). Learning Chinese Characters. p. 336.
10. "Marijuana and the Cannabinoids", ElSohly (p.8)
11. Leary, Thimothy (1990). Tarcher & Putnam (ed.). Flashbacks. New York: G.P. Putnam's Sons. ISBN 0-8747-7870-0.
12. Miller, Ga (1911). Encyclopædia Britannica. Vol. 34 (11th ed.). pp. 761–762. doi:10.1126/science.34.883.761. PMID 17759460. {{cite book}}: |journal= ignored (help)
13. Rudgley, Richard (1998). Little, Brown; et al. (eds.). The Encyclopedia of Psychoactive Substances. {{cite book}}: Explicit use of et al. in: |editor= (help)
14. Franck, Mel (1997). Marijuana Grower's Guide. Red Eye Press. ISBN 0-9293-4903-2. p. 3.
15. Rubin, Vera D. (1976). Cannabis and Culture. Campus Verlag. ISBN 3-5933-7442-0. p. 305.
16. Cunliffe, Barry W. (2001). The Oxford Illustrated History of Prehistoric Europe. Oxford University Press. ISBN 0-1928-5441-0. p. 405.
17. "Lab work to identify 2,800-year-old mummy of shaman". People's Daily Online. 2006.
18. Hong-En Jiang; et al. (2006). "A new insight into Cannabis sativa (Cannabaceae) utilization from 2500-year-old Yanghai tombs, Xinjiang, China". Journal of Ethnopharmacology. 108 (3): 414–422. doi:10.1016/j.jep.2006.05.034. PMID 16879937. {{cite journal}}: Explicit use of et al. in: |author= (help)
19. Walton, Robert P. (1938). Marijuana, America's New Drug Problem. J. B. Lippincott. p. 6.
20. "Cannabis linked to Biblical healing". BBC News. 2003-01-06. Retrieved 2009-12-31.
21. Ibn Taymiyya (2001). Le haschich et l'extase. Beyrouth: Albouraq. ISBN 2-8416-1174-4.
22. "Bard 'used drugs for inspiration'". BBC News. BBC. 2001-03-01. Retrieved 2009-08-07. {{cite news}}: Cite has empty unknown parameter: |coauthors= (help)
23. "Drugs clue to Shakespeare's genius". CNN. Turner Broadcasting System. 2001-03-01. Retrieved 2009-08-07. {{cite news}}: Cite has empty unknown parameter: |coauthors= (help)
24. "Marijuana Conspiracy - by Dough Yurchey". World-mysteries.com. Retrieved 2010-01-02.
25. William Randolf Hearst, Lammont Dupont, Henry J. Anslinger, and hemp [Archive] - DiscussAnything.com.
26. <http://www.ireport.com/docs/DOC-237709
27. "Cure Cancer with Hemp Oil - Phoenix Tears".
28. "Debunking the Hemp Conspiracy Theory".
29. "High Times in Ag Science: Marijuana More Potent Than Ever | Wired Science". Wired.com. 2008-12-22. Retrieved 2010-01-02.
30. "Marijuana- Definitions from Dictionary.com". dictionary.reference.com.
31. "Hemp Facts". Naihc.org. Retrieved 2010-01-02.
32. "Hashish - Definitions from Dictionary.com". dictionary.reference.com.
33. "UKCIA Soapbar warning - cannabis conamination - don't buy soapbar!". Ukcia.org. Retrieved 2010-01-02.
34. ^ "FRANK - Cannabis". Talktofrank.com. Retrieved 2010-01-02.
35. "Feature - Dr Russell Newcome on the ACMD report on cannabis : 2006-02-07". Lifeline Project. 2006-02-07. Retrieved 2010-01-02.
36. "Hash Oil Info".
37. "Kief | Cannabis Culture Magazine". Cannabisculture.com. Retrieved 2010-01-02.
38. "Pipe Residue Information".
39. ^ "Why Does Cannabis Potency Matter?". United Nations Office on Drugs and Crime. 2009-06-29.
40. ElSohly MA, Ross SA, Mehmedic Z, Arafat R, Yi B, Banahan BF (2000). "Potency Trends of delta9-THC and Other Cannabinoids in Confiscated Marijuana from 1980-1997". Journal of Forensic Sciences. 45 (1): 24–30. PMID 10641915. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
42. "Cannabis Potency". National Cannabis Prevention and Information Centre.
43. "ChemSpider - THC".
44. "ChemSpider - Cannabinol".
45. "Decarboxylation - Does Marijuana Have to be Heated to Become Psychoactive?".
46. "ChemIDplus Lite". chem.sis.nlm.nih.gov.
47. "Marijuana and the Brain, Part II: The Tolerance Factor".
48. Riedel G, Davies SN (2005). "Cannabinoid function in learning, memory and plasticity". Handb Exp Pharmacol (168): 445–477. PMID 16596784.
49. Long-Term Effects of Exposure to Cannabis.
50. Adverse Effects of Cannabis on Health: An Update of the Literature Since 1996.
51. McKim, William A (2002). Drugs and Behavior: An Introduction to Behavioral Pharmacology (5th Edition). Prentice Hall. p. 400. ISBN 0-13-048118-1.
52. "Information on Drugs of Abuse". Commonly Abused Drug Chart.
53. Harris, G. (18 January 2010). "Researchers find study of medical marijuana discouraged". New York Times. New York. Retrieved 19 January 2010.
54. "Medical Frequently Asked Questions". NORML. Retrieved 2010-01-02.
55. FDA: Inter-Agency Advisory Regarding Claims That Smoked Marijuana Is a Medicine
56. ""Frequently Asked Questions - Medical Marihuana"". Hc-sc.gc.ca. Retrieved 2010-01-02.
57. "Medical cannabis - Misplaced Pages, the 💕". En.wikipedia.org. Retrieved 2010-01-02.
58. Franjo Grotenhermen (2001). "Harm Reduction Associated with Inhalation and Oral Administration of Cannabis and THC". Journal of Cannabis Therapeutics. 1 (3–4): 133–152. doi:10.1300/J175v01n03_09. {{cite journal}}: Unknown parameter |month= ignored (help)
59. Earleywine M, Barnwell SS (2007). "Decreased Respiratory Symptoms in Cannabis Users Who Vaporize". Harm Reduction Journal. 4: 11. doi:10.1186/1477-7517-4-11. PMC 1853086. PMID 17437626.{{cite journal}}: CS1 maint: unflagged free DOI (link)
60. Abrams DI, Vizoso HP, Shade SB, Jay C, Kelly ME, Benowitz NL (2007). "Vaporization as a Smokeless Cannabis Delivery System: A Pilot Study". Clinical Pharmacology and Therapeutics. 82 (5): 572–578. doi:10.1038/sj.clpt.6100200. PMID 17429350. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
61. Hazekamp A, Ruhaak R, Zuurman L, van Gerven J, Verpoorte R (2006). "Evaluation of a vaporizing device (Volcano) for the pulmonary administration of tetrahydrocannabinol". Journal of Pharmaceutical Sciences. 95 (6): 1308–1317. doi:10.1002/jps.20574. PMID 16637053. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
62. Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 17382831, please use {{cite journal}} with |pmid=17382831 instead.
63. "Cannabis bigger cancer risk than cigarettes: study". Thomson Reuters.
64. "Study Finds No Link Between Marijuana Use And Lung Cancer". Science Daily. 2006-05-26.
65. Liang C, McClean MD, Marsit C; et al. (2009). "A population-based case-control study of marijuana use and head and neck squamous cell carcinoma". Cancer Prev Res (Phila Pa). 2 (8): 759–68. doi:10.1158/1940-6207.CAPR-09-0048. PMID 19638490. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
66. "Study Finds No Cancer-Marijuana Connection". Washington Post. . {{cite news}}: Check date values in: |date= (help)
67. "Marijuana compound may stop spread of breast cancer". Fox News. 2007-11-19.
68. Henquet C, Krabbendam L, Spauwen J; et al. (2005). "Prospective Cohort Study of Cannabis Use, Predisposition for Psychosis, and Psychotic Symptoms in Young People". British Medical Journal. 330 (7481): 11. doi:10.1136/bmj.38267.664086.63. PMC 539839. PMID 15574485. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
69. Patton GC, Coffey C, Carlin JB, Degenhardt L, Lynskey M, Hall W (2002). "Cannabis Use and Mental Health in Young People: Cohort Study". British Medical Journal. 325 (7374): 1195–1198. doi:10.1136/bmj.325.7374.1195. PMC 135489. PMID 12446533. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
70. Moore THM, Zammit S, Lingford-Hughes A; et al. (2007). "Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review". Lancet. 370 (9584): 319–328. doi:10.1016/S0140-6736(07)61162-3. PMID 17662880. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
71. Fergusson DM, Horwood LJ, Ridder EM (2005). "Tests of Causal Linkages Between Cannabis Use and Psychotic Symptoms". Addiction. 100 (3): 354–366. doi:10.1111/j.1360-0443.2005.01001.x. PMID 15733249. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
72. Hall, Wayne; Degenhardt, Lousia; Teesson, Maree. "Cannabis Use and Psychotic Disorders: An Update". Office of Public Policy and Ethics, Institute for Molecular Bioscience University of Queensland Australia, and National Drug and Alcohol Research Centre University of New South Wales Australia published in Drug and Alcohol Review (December 2004). Vol 23 Issue 4. pp. 433–443.
73. Arseneault, Louise; Cannon, Mary; Wiitton, John; Murray, Robin M. "Causal Association Between Cannabis and Psychosis: Examination of the Evidence". Institute of Psychiatry published in British Journal of Psychiatry (2004). #184, pp. 110–117.
74. Halpin SF, Yeoman L, Dundas DD (1991). "Radiographic examination of the lumbar spine in a community hospital: an audit of current practice". BMJ (Clinical Research Ed.). 303 (6806): 813–815. doi:10.1136/bmj.303.6806.813. PMC 1671162. PMID 1932970. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
75. Mukamal KJ, Maclure M, Muller JE, Mittleman MA (2008). "An exploratory prospective study of marijuana use and mortality following acute myocardial infarction". American Heart Journal. 155 (3): 465–70. doi:10.1016/j.ahj.2007.10.049. PMC 2276621. PMID 18294478. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
76. Gonzalez R (2007). "Acute and Non-Acute Effects of Cannabis on Brain Functioning and Neuropsychological Performance". Neuropsychology Review. 17 (3): 347–61. doi:10.1007/s11065-007-9036-8. PMID 17680367. {{cite journal}}: Unknown parameter |month= ignored (help)
77. "Electronenmicroscopisch onderzoek van vervuilde wietmonsters" (PDF).
78. "Department of Health, Social Services and Public Safety - Contamination of herbal or 'skunk-type' cannabis with glass beads" (PDF).
79. "Department of Health, Social Services and Public Safety - Update on seizures of cannabis contaminated with glass particles" (PDF).
80. Busse F, Omidi L, Timper K; et al. (2008). "Lead poisoning due to adulterated marijuana". N. Engl. J. Med. 358 (15): 1641–2. doi:10.1056/NEJMc0707784. PMID 18403778. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
81. Venhuis BJ, de Kaste D (2008). "Sildenafil analogs used for adulterating marijuana". Forensic Sci. Int. 182 (1–3): e23–4. doi:10.1016/j.forsciint.2008.09.002. PMID 18945564. {{cite journal}}: Unknown parameter |month= ignored (help)
82. Lundin, Leigh (2009-03-01). "The Great Smoke-Out". Criminal Brief.
83. ^ "RAND study casts doubt on claims that marijuana acts as "gateway" to the use of cocaine and heroin". RAND Corporation. 2002-12-02.
84. ^ Torabi MR, Bailey WJ, Majd-Jabbari M (1993). "Cigarette Smoking as a Predictor of Alcohol and Other Drug Use by Children and Adolescents: Evidence of the "Gateway Drug Effect"". The Journal of School Health. 63 (7): 302–306. doi:10.1111/j.1746-1561.1993.tb06150.x. PMID 8246462.{{cite journal}}: CS1 maint: multiple names: authors list (link)
85. Australian Government Department of Health: National Cannabis Strategy Consultation Paper, p. 4. "Cannabis has been described as a 'Trojan Horse' for nicotine addiction, given the usual method of mixing Cannabis with tobacco when preparing marijuana for administration."
86. Hall WD, Lynskey M (2005). "Is Cannabis A Gateway Drug? Testing Hypotheses About the Relationship Between Cannabis Use and the Use of Other Illicit Drugs". Drug and Alcohol Review. 24 (1): 39–48. doi:10.1080/09595230500126698. PMID 16191720. {{cite journal}}: Unknown parameter |month= ignored (help)
87. Saitz, Richard (2003-02-18). "Is marijuana a gateway drug?". Journal Watch.
88. Degenhardt, Louisa; et al. (2007). "Who are the new amphetamine users? A 10-year prospective study of young Australians". {{cite web}}: Explicit use of et al. in: |author= (help)
89. Morral AR, McCaffrey DF, Paddock SM (2002). "Reassessing the marijuana gateway effect". Addiction. 97 (12): 1493–504. doi:10.1046/j.1360-0443.2002.00280.x. PMID 12472629.{{cite journal}}: CS1 maint: multiple names: authors list (link)
90. "Marijuana Policy Project- FAQ".
91. Many Dutch coffee shops close as liberal policies change, Exaptica, 27/11/2007.
92. EMCDDA Cannabis reader: Global issues and local experiences, Perspectives on Cannabis controversies, treatment and regulation in Europe, 2008, p. 157.
93. 43 Amsterdam coffee shops to close door, Radio Netherlands, Friday 21 November 2008.
94. http://www.unodc.org/pdf/WDR_2005/volume_2_chap7_cannabis.pdf
95. "Report on U.S. Domestic Marijuana Production". NORML. Retrieved 2010-01-02.
96. "Marijuana Crop Reports". NORML. Retrieved 2010-01-02.
97. "Marijuana Called Top U.S. Cash Crop". 2008 ABCNews Internet Ventures.
98. United Nations Office on Drugs and Crime (2008). World drug report (PDF). United Nations Publications. p. 264. ISBN 978-92-1-148229-4.
99. European Monitoring Centre for Drugs and Drug Addiction (2008). Annual report: the state of the drugs problem in Europe (PDF). Luxembourg: Office for Official Publications of the European Communities. p. 38. ISBN 978-92-9168-324-6.
100. http://www.southyorks.police.uk/news/newssyp/dearnesaferneighbourhoodteamsntrecoverscannabisstreetvalueapproximately£9000
101. ^ Cockburn, Alexander (1998). Whiteout: The CIA, Drugs and the Press. Verso. pp. 117–118. ISBN 1859841392. {{cite book}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)
102. Daniel Forbes (November 19, 2002). "The Myth of Potent Pot". Slate.com.
103. "World Drug Report 2006". United Nations Office on Drugs and Crime. Ch. 2.3.
104. "High-potency cannabis and the risk of psychosis - Di Forti et al. 195 (6): 488 - The British Journal of Psychiatry". Bjp.rcpsych.org. doi:10.1192/bjp.bp.109.064220. Retrieved 2010-01-02.
105. BBC: Cannabis laws to be strengthened. May 2008 20:55 UK.
106. "Dutch-Passion - Power Plant ®, Powerplant (mostly Sativa) was developed by us in 1997 from new South African genetics. This". Cgi.dutch-passion.nl. Retrieved 2010-01-02.
107. Tj. T. Mensinga; et al. "A Double-Blind, Randomized, Placebo-Controlled, Cross-Over Study on the Pharmacokinetics and Effects of Cannabis" (PDF). RIVM. {{cite web}}: Explicit use of et al. in: |author= (help)
108. Curran H.V.; et al. (2002). "Cognitive and subjective dose-response effects". NCBI. {{cite web}}: Explicit use of et al. in: |author= (help)
109. "Marijuana Dictionary".

Further reading

• Booth, Martin (2005). Cannabis: A History. Macmillan Publishers & Random House, Inc. ISBN 978-0-312-42494-7. | url = http://books.google.com/books?id=O7AoY6ljSygC&printsec=frontcover}}

External links

• Wiktionary Appendix of Cannabis Slang
• National Organization for the Reform of Marijuana Laws
• National Cannabis Prevention and Information Centre
• Tobacco and Marijuana Market Impact Index - National Trends

• Cannabis
• Psychedelics, dissociatives and deliriants